View Item 

Show simple item record

Relationship Between Salivary Melatonin and Severity of Periodontal Disease
dc.contributor.authorCutando, Antonio
dc.contributor.authorGalindo, Pablo
dc.contributor.authorGómez‐moreno, Gerardo
dc.contributor.authorArana, Carlos
dc.contributor.authorBolaños, Jorge
dc.contributor.authorAcuña‐castroviejo, Darío
dc.contributor.authorWang, Hom‐lay
dc.date.accessioned2018-02-05T16:36:20Z
dc.date.available2018-02-05T16:36:20Z
dc.date.issued2006-09
dc.identifier.citationCutando, Antonio; Galindo, Pablo; Gómez‐moreno, Gerardo ; Arana, Carlos; Bolaños, Jorge ; Acuña‐castroviejo, Darío ; Wang, Hom‐lay (2006). "Relationship Between Salivary Melatonin and Severity of Periodontal Disease." Journal of Periodontology 77(9): 1533-1538.
dc.identifier.issn0022-3492
dc.identifier.issn1943-3670
dc.identifier.urihttps://hdl.handle.net/2027.42/141566
dc.publisherAmerican Academy of Periodontology
dc.publisherWiley Periodicals, Inc.
dc.subject.otherplasma
dc.subject.otherperiodontal diseases
dc.subject.othersaliva
dc.subject.otherMelatonin
dc.subject.otherperiodontal index
dc.titleRelationship Between Salivary Melatonin and Severity of Periodontal Disease
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDentistry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI.
dc.contributor.affiliationotherDepartment of Physiology, Institute of Biotechnology, University of Granada.
dc.contributor.affiliationotherStatistics and Operational Research Department, Faculty of Library Science and Documentation, University of Granada.
dc.contributor.affiliationotherDepartment of Oral Surgery, School of Dentistry, University of Granada.
dc.contributor.affiliationotherDepartment of Special Care in Dentistry, School of Dentistry, University of Granada, Granada, Spain.
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141566/1/jper1533.pdf
dc.identifier.doi10.1902/jop.2006.050287
dc.identifier.sourceJournal of Periodontology
dc.identifier.citedreferenceGarcíaâ Maurino S, Gonzálezâ Haba MG, Calvo JR, Goberna R, Guerrero JM. Involvement of nuclear binding sites for melatonin in the regulation of ILâ 2 and ILâ 6 production by human blood mononuclear cells. J Neuroimmunol 1998; 92: 76 â 84.
dc.identifier.citedreferenceReiter R, Tang L, García JJ, Muñozâ Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997; 60: 2255 â 2271.
dc.identifier.citedreferenceReiter RJ. Cytoprotective properties of melatonin: Presumed association with oxidative damage and aging. Nutrition 1998; 14: 691 â 696.
dc.identifier.citedreferenceReiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 2000; 917: 376 â 386.
dc.identifier.citedreferenceMaestroni GJ. The immunotherapeutic potential of melatonin. Expert Opin Investig Drugs 2001; 10: 467 â 476.
dc.identifier.citedreferenceGarcíaâ Maurino S, Pozo D, Calvo JR, Guerrero JM. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocyte cell lines. J Pineal Res 2000; 29: 129 â 137.
dc.identifier.citedreferenceNakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 1999; 27: 106 â 110.
dc.identifier.citedreferenceKoyama H, Nakade O, Takada Y, Kaku T, Lay KH. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through downâ regulation of the RANKLâ mediated osteoclast formation and activation. J Bone Miner Res 2002; 17: 1219 â 1229.
dc.identifier.citedreferenceLaakso ML, Porkkaâ Heiskanen T, Alila A, Stenberg D, Johansson NG. Correlation between salivary and serum melatonin: Dependence on serum melatonin levels. J Pineal Res 1990; 9: 39 â 50.
dc.identifier.citedreferenceMcIntyre IM, Norman TR, Burrows GD, Armstrong SM. Melatonin rhythm in human plasma and saliva. J Pineal Res 1987; 4: 177 â 183.
dc.identifier.citedreferenceMandel ID. Sialochemistry in diseases and clinical situations affecting salivary glands. Crit Rev Clin Lab Sci 1980; 12: 321 â 366.
dc.identifier.citedreferenceVakkuri O. Diurnal rhythm of melatonin in human saliva. Acta Physiol Scand 1985; 124: 409 â 412.
dc.identifier.citedreferenceCutando A, Gómezâ Moreno G, Villalba J, Ferrera MJ, Escames G, Acuñaâ Castroviejo D. Relationship between salivary melatonin levels and periodontal status in diabetic patients. J Pineal Res 2003; 35: 239 â 244.
dc.identifier.citedreferenceWorld Health Organization. Oral Health Surveys: Basic Methods, 4th ed. Geneva: World Health Organization; 1987: 31 â 32.
dc.identifier.citedreferenceMiles A, Thomas DR, Grey JE, Pugh AJ. Salivary melatonin assay in laboratory medicine longitudinal profiles of secretion in healthy men. Clin Chem 1987; 33: 1957 â 1959.
dc.identifier.citedreferenceArendt J, Paunier L, Sizonenko PC. Melatonin radioimmunoassay. J Clin Endocrinol Metab 1975; 40: 347 â 350.
dc.identifier.citedreferenceAcuñaâ Castroviejo D, Escames G, Carazo A, León J, Khaldy H, Reiter RJ. Melatonin mitochondrial homeostasis and mitochondrialâ related diseases. Curr Top Med Chem 2002; 2: 133 â 151.
dc.identifier.citedreferenceReiter RJ. Aging and oxygen toxicity: Relation to changes in melatonin. Age (Omaha) 1997; 20: 201 â 213.
dc.identifier.citedreferenceCardinali DP, Ladizesky MG, Boggio V, Cutrera RA, Mautalen C. Melatonin effects on bone: Experimental facts and clinical perspectives. J Pineal Res 2003; 34: 81 â 87.
dc.identifier.citedreferenceBoyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423: 337 â 342.
dc.identifier.citedreferenceLiu D, Xu J, Figliomeni L, et al. Expression of RANKL and OPG mRNA in periodontal disease: Possible involvement in bone destruction. Int J Mol Med 2003; 11: 17 â 21.
dc.identifier.citedreferenceTheoleyre S, Wittrant Y, Kwan Tat S, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: Involvement in the orchestration of pathophysiological bone remodelling. Cytokine Growth Factor Rev 2004; 15: 457 â 475.
dc.identifier.citedreferenceMasui T, Sakano S, Hasegawa Y, Warashina H, Ishiguro N. Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobaltâ chromium and polyethylene particles. Biomaterials 2005; 26: 1695 â 1702.
dc.identifier.citedreferenceTakahashi N, Nobuyuki U, Takami M, Suda T. Cells of bone. Osteoclast generation. In: Bilezikian J, Raisz L, Rodan G, eds. Principles of Bone Biology, 2nd ed. San Diego: Academic Press; 2002: 109 â 126.
dc.identifier.citedreferenceSandyk R, Anastasiadis P, Anninos P, Tsagas N. Is postmenopausal osteoporosis related to pineal gland functions? Int J Neurosci 1992; 62: 215 â 225.
dc.identifier.citedreferenceOstrowska Z, Kosâ Kudla B, Swietochowska E, Marek B, Kajdaniuk D, Gorski J. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis. Neuroendocrinol Lett 2001; 22: 129 â 136.
dc.identifier.citedreferenceGuerrero J, Pozo D, Garcíaâ Mauriño S, Osuna C, Molinero P, Calvo J. Involvement of nuclear receptors in the enhanced ILâ 2 production by melatonin in Jurkat cells. Ann N Y Acad Sci 2000; 917: 397 â 403.
dc.identifier.citedreferenceVäänänen K, Zhao H. Osteoclast function. Biology and mechanism. In: Bilezikian J, Raisz L, Rodan G, eds. Principles of Bone Biology, 2nd ed. San Diego: Academic Press; 2002: 127 â 141.
dc.identifier.citedreferenceRoth J, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 1999; 274: 22041 â 22047.
dc.identifier.citedreferenceBattino M, Bullón P, Wilson M, Newman H. Oxidative injury and inflammatory periodontal diseases: The challenge of antiâ oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med 1999; 10: 458 â 476.
dc.identifier.citedreferenceReiter RJ. Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151 â 180.
dc.identifier.citedreferenceReiter RJ, Tan DX, Acuñaâ Castroviejo D, Burkhardt S, Karbownik M. Melatonin: Mechanics and actions as an antioxidant. Curr Top Biophys 2001; 24: 171 â 183.
dc.identifier.citedreferenceMarshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996; 21: 307 â 315.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jper1533.pdf
Size:
203.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.